Viewing nowCombinationEslyptin Tablet 10/100 mg
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.

MFDS item code 202200491 · Approved 2022.01.28 · Insurance code 660703830
Improvement in blood sugar control for type 2 diabetes
This medication helps patients with type 2 diabetes manage their blood sugar levels more effectively when combined with diet and exercise. The ingredients sitagliptin and dapagliflozin work together to improve blood sugar levels and aid in blood sugar management. Therefore, this medication is used for type 2 diabetes that requires additional blood sugar control beyond diet and exercise.
This medication can be administered as one tablet daily, regardless of meals, to patients receiving 100 mg of sitagliptin and 10 mg of dapagliflozin. The tablet should be swallowed whole.
This medication is used for the treatment of diabetes, and severe allergic reactions may occur during use, so caution is advised. If symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur after taking the medication, discontinue use immediately and consult a physician. There is a risk of acute pancreatitis, which is inflammation of the pancreas, so if symptoms such as abdominal pain, nausea, or vomiting occur after taking the medication, visit a medical facility immediately. This medication should not be used in patients with certain genetic problems, type 1 diabetes, or patients undergoing dialysis. Patients with decreased kidney function should adjust to a lower dose, and special attention should be paid to older patients or those with reduced fluid volume, regularly checking blood pressure and kidney function. During use, symptoms of hypoglycemia may occur, so caution is necessary when used with insulin or other hypoglycemic agents. The risk of genital and urinary tract infections may increase, so if symptoms of infection appear in those areas, treatment should be sought immediately. Weight loss, dehydration, and hypotension may occur, so monitor your condition closely and consult medical personnel if there are any concerns. It is advisable for pregnant or breastfeeding women to avoid using this medication, and if pregnancy is confirmed, use should be discontinued. The safety and effectiveness of this medication have not been established in children and adolescents under 18 years of age. In case of overdose, there is no specific antidote, so appropriate treatment should be received based on symptoms, and blood dialysis may be considered if necessary. Caution is needed when driving or operating machinery during the use of this medication, especially if there is a risk of hypoglycemia. Store the medication in its original container, avoiding direct sunlight and keeping it out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius. This will help preserve the medication's effectiveness and safety over time.
Yellow rectangular film-coated tablet
28 tablets/box - 28 tablets/box [(7 tablets/PTP x 4)], 30 tablets/box - 30 tablets/box [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Ilsung IS Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Chodang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.